국내 제약회사의 효율성 및 생산성 분석

Abstract

According to a Korea Pharmaceutical Manufacturers Association, the world pharmaceutical market in 2009 is about 8,370 billion dollars, to be worth 925 trillion won were analyzed. In addition, by 2010 the world's 10 largest pharmaceutical market in the world pharmaceutical companies accounted for more than 40% of total revenue. Domestic pharmaceutical market by 2010 about 17 trillion won will be evaluated, that portion of the production of approximately 14 trillion, one trillion parts exports, imports accounted for part 2 trillion won. The first half of this year, sales of domestic pharmaceutical companies looked at operating profit and net profit, revenue decline and showed for the first time ever. This is due to government regulation of the powerful pharmaceutical industry,high-strength medicine was acting as the primary cause cuts, increased competition with global pharmaceutical companies, expanding FTA between countries, including lack of experience in global drug combination. and the uncertainty of business environment is considered. Business managers in the uncertainty of business environment are needed to improve operational efficiencies and productivity improvement. This study of the pharmaceutical industry, these companies meet the changing business environment, assess the efficiency and productivity and management improvement to provide information for the quantitative empirical analysis was conducted. The findings derived from empirical analysis of individual pharmaceutical companies,along with financial indicators to determine the company's efficiency and productivity and could be the basis for the pharmaceutical industry on government policy and the global pharmaceutical industry for the long-term Master Plan.